Amie Adjakple
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Amie Adjakple has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Bethany Stetson
Northwestern University Feinberg School of Medicine, Chicago, IL, United States
2 shared publications - Danna Tortal
Yale School of Medicine, New Haven, CT, United States
2 shared publications - Ester Sanchez
Weill Medical College of Cornell University, New York, NY (Garcia and Sanchez)
2 shared publications - Jessica Leventhal
Yale University, New Haven, CT, United States
2 shared publications - Moeun Son
Division of Maternal‐Fetal Medicine Department of Obstetrics and Gynecology Weill Cornell Medical College New York New York USA
2 shared publications - Molly McAdow
Department of Obstetrics, Gynecology, & Reproductive Sciences Yale School of Medicine New Haven Connecticut USA
2 shared publications
Latest Publications
- Open Access
- 20 June 2024
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 13, e63463
Stimulation Therapy to Induce Mothers (STIM): Protocol for a Multicenter Randomized Controlled Trial (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Over 1 million women have their labor induced in the United States each year, and synthetic oxytocin infusion is the most common method used. However, compared to spontaneous labor, medical induction is resource-intensive, has increased obstetric risks, and is associated with less successful breastfeeding. In contrast to endogenous oxytocin hormone which is released in a pulsatile fashion in the brain, synthetic oxytocin is continuously infused intravenously, resulting in important limitations related to efficacy, safety, and cost. Akin to spontaneous labor contractions, infant suckling of the breast nipple is known to stimulate the pulsatile release of endogenous oxytocin from the posterior pituitary gland. Nipple stimulation therapy via electric breast pump similarly stimulates endogenous oxytocin release and may be a favorable inpatient method for patients undergoing labor induction. Objective: To examine whether inpatient nipple stimulation therapy is an efficacious labor induction method that increases the likelihood of spontaneous vaginal delivery and sustained breastfeeding and determine whether it is a cost-effective approach. Methods: This is a multicenter, pragmatic, open-label, parallel group randomized trial of nulliparous patients with singleton gestations 36 weeks undergoing labor induction. This trial compares inpatient nipple stimulation therapy via electric breast pump versus immediate synthetic oxytocin infusion without nipple stimulation. This trial of 988 nulliparas will provide adequate statistical power to detect clinically meaningful differences in delivery mode and breastmilk as the sole source of nutrition for newborns at hospital discharge or 72 hours of birth. Results: The project received pilot funding in 2021 and full funding in 2023. Enrollment began in November 2021 at a single site and is now being conducted at three recruiting sites. It is anticipated that enrollment will be completed in late 2026. Conclusions: Successful completion of this trial will provide rigorous data to determine whether inpatient nipple stimulation therapy with an electric breast pump can improve the way we induce labor and positively impact breastfeeding success and early infant nutrition through lactation. Clinical Trial: ClinicalTrials.gov NCT05079841
- 20 June 2024
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 13, e63463
Open AccessStimulation Therapy to Induce Mothers (STIM): Protocol for a Multicenter Randomized Controlled Trial (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Over 1 million women have their labor induced in the United States each year, and synthetic oxytocin infusion is the most common method used. However, compared to spontaneous labor, medical induction is resource-intensive, has increased obstetric risks, and is associated with less successful breastfeeding. In contrast to endogenous oxytocin hormone which is released in a pulsatile fashion in the brain, synthetic oxytocin is continuously infused intravenously, resulting in important limitations related to efficacy, safety, and cost. Akin to spontaneous labor contractions, infant suckling of the breast nipple is known to stimulate the pulsatile release of endogenous oxytocin from the posterior pituitary gland. Nipple stimulation therapy via electric breast pump similarly stimulates endogenous oxytocin release and may be a favorable inpatient method for patients undergoing labor induction. Objective: To examine whether inpatient nipple stimulation therapy is an efficacious labor induction method that increases the likelihood of spontaneous vaginal delivery and sustained breastfeeding and determine whether it is a cost-effective approach. Methods: This is a multicenter, pragmatic, open-label, parallel group randomized trial of nulliparous patients with singleton gestations 36 weeks undergoing labor induction. This trial compares inpatient nipple stimulation therapy via electric breast pump versus immediate synthetic oxytocin infusion without nipple stimulation. This trial of 988 nulliparas will provide adequate statistical power to detect clinically meaningful differences in delivery mode and breastmilk as the sole source of nutrition for newborns at hospital discharge or 72 hours of birth. Results: The project received pilot funding in 2021 and full funding in 2023. Enrollment began in November 2021 at a single site and is now being conducted at three recruiting sites. It is anticipated that enrollment will be completed in late 2026. Conclusions: Successful completion of this trial will provide rigorous data to determine whether inpatient nipple stimulation therapy with an electric breast pump can improve the way we induce labor and positively impact breastfeeding success and early infant nutrition through lactation. Clinical Trial: ClinicalTrials.gov NCT05079841
- Open Access
- 20 June 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Stimulation Therapy to Induce Mothers: Protocol for a Multicenter Randomized Controlled Trial (Preprint)
BACKGROUND More than 1 million women have their labor induced in the United States each year, and synthetic oxytocin infusion is the most common method used. However, compared to spontaneous labor, medical induction is resource intensive, has increased obstetric risks, and is associated with less successful breastfeeding. In contrast to the endogenous oxytocin hormone, which is released in a pulsatile fashion in the brain, synthetic oxytocin is continuously infused intravenously, resulting in important limitations related to efficacy, safety, and cost. Akin to spontaneous labor contractions, infant suckling of the breast nipple is known to stimulate the pulsatile release of endogenous oxytocin from the posterior pituitary gland. Nipple stimulation therapy via an electric breast pump similarly stimulates endogenous oxytocin release and may be a favorable inpatient method for patients undergoing labor induction. OBJECTIVE This study aims to examine whether inpatient nipple stimulation therapy is an efficacious labor induction method that increases the likelihood of spontaneous vaginal delivery and sustained breastfeeding and determine whether it is a cost-effective approach. METHODS This is a multicenter, pragmatic, open-label, parallel-group randomized controlled trial of nulliparous patients with singleton gestations ≥36 weeks undergoing labor induction. This trial compares inpatient nipple stimulation therapy via an electric breast pump versus immediate synthetic oxytocin infusion without nipple stimulation. This trial including 988 nulliparas will provide adequate statistical power to detect clinically meaningful differences in delivery mode and breast milk as the sole source of nutrition for newborns at hospital discharge or 72 hours after birth. RESULTS The project received pilot funding in 2021 and full funding in 2023. Enrollment for this study began in November 2021 at a single site, and as of May 2024, recruitment is underway at 3 study sites. It is anticipated that enrollment will be completed by late 2026. CONCLUSIONS Successful completion of this trial will provide rigorous data to determine whether inpatient nipple stimulation therapy with an electric breast pump can improve the way we induce labor and positively impact breastfeeding success and early infant nutrition through lactation. CLINICALTRIAL ClinicalTrials.gov NCT05079841; https://clinicaltrials.gov/study/NCT05079841 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/63463
- 20 June 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessStimulation Therapy to Induce Mothers: Protocol for a Multicenter Randomized Controlled Trial (Preprint)
BACKGROUND More than 1 million women have their labor induced in the United States each year, and synthetic oxytocin infusion is the most common method used. However, compared to spontaneous labor, medical induction is resource intensive, has increased obstetric risks, and is associated with less successful breastfeeding. In contrast to the endogenous oxytocin hormone, which is released in a pulsatile fashion in the brain, synthetic oxytocin is continuously infused intravenously, resulting in important limitations related to efficacy, safety, and cost. Akin to spontaneous labor contractions, infant suckling of the breast nipple is known to stimulate the pulsatile release of endogenous oxytocin from the posterior pituitary gland. Nipple stimulation therapy via an electric breast pump similarly stimulates endogenous oxytocin release and may be a favorable inpatient method for patients undergoing labor induction. OBJECTIVE This study aims to examine whether inpatient nipple stimulation therapy is an efficacious labor induction method that increases the likelihood of spontaneous vaginal delivery and sustained breastfeeding and determine whether it is a cost-effective approach. METHODS This is a multicenter, pragmatic, open-label, parallel-group randomized controlled trial of nulliparous patients with singleton gestations ≥36 weeks undergoing labor induction. This trial compares inpatient nipple stimulation therapy via an electric breast pump versus immediate synthetic oxytocin infusion without nipple stimulation. This trial including 988 nulliparas will provide adequate statistical power to detect clinically meaningful differences in delivery mode and breast milk as the sole source of nutrition for newborns at hospital discharge or 72 hours after birth. RESULTS The project received pilot funding in 2021 and full funding in 2023. Enrollment for this study began in November 2021 at a single site, and as of May 2024, recruitment is underway at 3 study sites. It is anticipated that enrollment will be completed by late 2026. CONCLUSIONS Successful completion of this trial will provide rigorous data to determine whether inpatient nipple stimulation therapy with an electric breast pump can improve the way we induce labor and positively impact breastfeeding success and early infant nutrition through lactation. CLINICALTRIAL ClinicalTrials.gov NCT05079841; https://clinicaltrials.gov/study/NCT05079841 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/63463